【關於晟德創創】
晟德以「藥業」起家，投資育成之企業超過20家並已有8家公司成功上櫃或興櫃，具備生技實務經驗與商業專業知識、熟稔產業價值鏈與生態並擁有完整專家網絡及資源整合能力，為亞太最專業的生技育成平台。
為鼓勵創新創業，晟德推出「晟德創創專案」，期待透過自身專業、紮實的產業實務經驗以及豐沛的人脈網絡，幫助有志青年創造更多顛覆想像、突破醫療現狀的解決方案！
「晟德創創專案」專注於藥品、醫材、營養保健及智慧醫療四大領域，通過Pitch複審的創業團隊將可獲得一筆創業基金並可與集團專家近距離請益、互動，激發創業靈感與火花。此外，更有機會獲得天使投資、成為晟德集團的一份子，共享集團六大育成資源！
Founded as a pharmaceutical company, we’ve invested in more than 20 companies, 8 of which have been successfully listed on the Stock Exchange or the Emerging Stock Market. We are equipped with practical experience and business expertise in biotechnology. Our familiarity with the industry value chain and ecosystem, along with complete expert network and resource integration capabilities, make us the most professional biotechnology incubator platform in Asia Pacific.
To encourage innovation and entrepreneurship, Center Ventures launches the “Center Innovation Project” in hopes of supporting aspiring young scientists to create breakthrough medical solutions that subvert your imagination. Center Ventures will provide its professional, extensive, and practical industry experience, along with a wide network of connections.
“Center Innovation Project” focuses on the fields of pharmaceuticals, medical devices, nutritional health, and smart healthcare. Qualified startup teams selected after the pitch may receive venture capital fund and interact with experts to stimulate entrepreneurial ideas and sparks.They also have a chance of securing angel funds and becoming one of our portfolio companies, where they will have access to the six core sources of values.
【晟德創創特色】
【重要時程】
-
即日起至3/31：開放收件，完成填寫「晟德創創專案」線上報名表
-
4/1-4/19：第一階段書面審查
-
4/26：主辦單位寄信通知通過第一階段者
-
5/3：通過第一階段者須於16:00以前提供Pitch簡報一份
-
5/13-5/24：第二階段面試審查(pitch)
-
5/31：公告入選團隊並寄信通知